Gliatech Confident ADCON-P Will Not Become Third Strike At FDA Panel

Gliatech is optimistic that lessons learned from the unfavorable experiences of Genzyme Tissue Repair and Lifecore Biomedical before FDA's General and Plastic Surgery Panel will help the firm when it steps up to the plate with its ADCON-P pelvic and gynecologic anti-adhesion solution.